car-t bms-986354 | luciano costa, md, phd | ash 2022
Published 1 year ago • 212 plays • Length 4:39
Download video MP4
Download video MP3
Similar videos
-
4:03
master trial update: mrd based response adaptive therapy | luciano costa, md, phd | ash 2021
-
1:03:16
what to do with your mrd results: starting or changing treatment- dr. luciano costa
-
4:21
phase 1 study phe885 bcma-directed car-t cell therapy for rrmm | adam sperling, md, phd | asco 2023
-
8:06
clinical activity of bms-986393, a car t cell therapy directed at gprc5d, in pts with rrmm
-
3:29
t cell redirection therapy | tarek mouhieddine, md | ash 2022
-
2:10
new developments at ash | rafat abonour, md | ash 2022
-
0:54
dr. costa on remaining challenges with car t-cell therapy in multiple myeloma
-
5:22
individualized prediction model in myeloma & genome sequencing | francesco maura, md | ash 2022
-
3:44
bispecific t cell engagers | noopur raje, md | ash 2022
-
4:59
improving car t-cell therapy | ciara freeman, md, phd
-
1:38
real world use of car t-cell therapy in multiple myeloma
-
4:23
what are car-t cells? how are they made? #myeloma
-
4:20
what is meant by an out of spec car-t product? #myeloma
-
6:50
bispecifics | urvi shah, md | ash 2022
-
9:33
talquetamab | ajai chari, md | ash 2022
-
4:17
car-t cell therapy cilta-cel for relapsed/refractory myeloma | doris hansen, md | asco 2023
-
2:27
bms-986393, a novel anti-gprc5d car-t cell therapy, in multiple myeloma
-
4:21
how to better diagnose patients with high-risk myeloma | martin kaiser, md | ash 2022
Clip.africa.com - Privacy-policy